
Let’s get phygital
This article explores 'phygital' technology, combining physical and digital elements, and its application in optometry, from virtual try-on eyewear to

This article explores 'phygital' technology, combining physical and digital elements, and its application in optometry, from virtual try-on eyewear to

'Ophthalmic Drug Delivery' is a comprehensive compendium of ocular pharmaceutical research, emphasising industrial and regulatory requirements to translate innovations from

Dr Arvind Gupta shares a case study of this rare retinochoroidal atrophy

As cutting-edge ZEISS diagnostic technology becomes increasingly prevalent in the ophthalmic industry, it has elevated patient care within a busy Auckland optometry practice. Frith Jenkins from Howick

A recent diagnosis of Parkinson’s disease has added an unexpected dimension to my personal and professional journey.

This article explains how buyers value an optometry practice for sale, focusing on adjusted EBITDA. It details key adjustments and levers like profitability and multiple that drive the

Dublin advanced nurse practitioner Diana Malata explains how Ireland's nurse-led crosslinking (CXL) programme has accelerated care for keratoconus patients,

This article reviews advances in paediatric blepharokeratoconjunctivitis treatment, the cost-effectiveness of keratoconus screening and crosslinking

Ocular melanoma, including choroidal, iris, and conjunctival types, is rare but serious. Early detection by optometrists and ophthalmologists through

If you have impostor syndrome, you're not alone!

Revisyon's developer responds to NZ eyecare professionals’ concerns about its safety and effectiveness

This month, Drew Jones covers Eye Institute’s Drs Peter Hadden’s and Sophie Hill’s responses to optometrists’ questions about vitrectomy recovery and counselling, anti-VEGF choices and emerging management options for geographic atrophy secondary to AMD. Answers have been abridged.
